Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Virtual Event

18 ago 2020 8:00 a.m. - 19 ago 2020 3:45 p.m.

(US Eastern Standard Time)

Fort Washington, PA 19034

Digital Technology in Clinical Trials

Session 7 Track 1&2: Can You Hear Me Now? How Platform Digital Technologies Can Amplify the Patient Voice

Session Chair(s)

Lauren  Oliva, PharmD, RPh

Lauren Oliva, PharmD, RPh

US Lead, Global Regulatory Policy

Biogen, United States

As our knowledge of disease manifestations and treatment approaches becomes more sophisticated, new opportunities exist to quantify important features of serious diseases for the first time.

There are now digital tools available to sponsors with the potential to create value in the drug development process beyond a specific product or disease state. These so-called platform technologies are tools that enable sponsors to better measure and interpret symptoms that impact many disease indications. Examples include symptoms such as fatigue, pain, cognition, speech, and autonomic measures.

This session will explore the value of adopting platform technologies to drug development programs and the path to regulatory acceptance of data generated by these novel tools.

Learning Objective :

At the conclusion of this session, participants should be able to:

  • Identify case study examples of platform digital technologies tools in drug development programs.
  • Propose benefits of data generated by these tools for patients, caregivers, HCPs, regulators, and payers
  • Evaluate models for cooperative development and adoption of platform digital technologies in the biopharma ecosystem

Speaker(s)

Kelley  Erb, PhD

Industry Perspectives on a Platform Approach to Digital Endpoint Development

Kelley Erb, PhD

Biogen, United States

Director, Digital and Quantitative Medicine

Michelle  Campbell, PhD

Industry Perspectives on a Platform Approach to Digital Endpoint Development

Michelle Campbell, PhD

FDA, United States

Associate Director, Stakeholder Engagement and Clinical Outcomes, ON, OND, CDER

Mintu  Turakhia, MD, MS

Operationalizing Digital Health and Virtual Visits for Clinical Trials

Mintu Turakhia, MD, MS

Stanford University , United States

Executive Director, Center for Digital Health; Chief of EP, Palo Alto VA

Channing  Barker

Speaker

Channing Barker

Advocate, United States

Patient Representative

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.